SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-080152
Filing Date
2021-06-11
Accepted
2021-06-11 16:21:20
Documents
13
Period of Report
2021-06-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2119430d1_8k.htm   iXBRL 8-K 36437
2 EXHIBIT 10.1 tm2119430d1_ex10-1.htm EX-10.1 79474
  Complete submission text file 0001104659-21-080152.txt   311417

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pcrx-20210608.xsd EX-101.SCH 3181
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE pcrx-20210608_lab.xml EX-101.LAB 34592
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pcrx-20210608_pre.xml EX-101.PRE 22707
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2119430d1_8k_htm.xml XML 3606
Mailing Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054 973-254-3560
Pacira BioSciences, Inc. (Filer) CIK: 0001396814 (see all company filings)

IRS No.: 510619477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35060 | Film No.: 211011567
SIC: 2834 Pharmaceutical Preparations